Current drug targets for Alzheimer's disease treatment
- 1 July 2002
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 56 (3), 267-281
- https://doi.org/10.1002/ddr.10081
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Targeting APP metabolism for the treatment of Alzheimer's diseaseDrug Development Research, 2002
- A Cargo Receptor Mystery APP arently Solved?Science, 2002
- Glia and Alzheimer's diseaseNeurochemistry International, 2001
- Untangling vascular dementiaThe Lancet, 2001
- Tauists and βaptists United--Well Almost!Science, 2001
- A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60Science, 2001
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Basic fibroblast growth factor in Alzheimer's diseaseBiochemical and Biophysical Research Communications, 1990
- Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's DiseaseNew England Journal of Medicine, 1989
- Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous SystemJournal of Neurochemistry, 1986